Levi & Korsinsky notifies investors that it has commenced an investigation into Tempus AI, Inc. (NASDAQ: TEM) concerning potential violations of the federal securities laws.
Spruce Point Capital Management ("Spruce Point") published a report on Tempus, on May 28, 2025, describing a number of "concerns" about the Company. Among other issues, the Spruce Point report asserted that the Company used "aggressive accounting and financial reporting"; that several members of the Company's Board and "other executives have been associated with troubled companies that restated financial results"; and that "[k]ey strategic partnerships and deal announcement[s] with AstraZeneca and Pathos AI merit scrutiny." Following this news, Tempus's stock price fell sharply during intraday trading on the same day.
If you suffered a loss on your Tempus AI, Inc. securities and would like to explore a potential recovery under the federal securities laws, submit to us or contact Joseph E. Levi, Esq. via email at [email protected] or call 212-363-7500 to speak to our team of experienced shareholder advocates.
Please provide your address so we can contact you about your case if eligible.






Input your stock purchases and sales












Connect with SnapTrade to let us the stocks you own. This is an optional step to keep you. informed about class action litigation.
✓ Fast: takes less than a min
✓ We do not create an attorney-client relationship
✓ Your information is confidential & secure





